Page 45 of 72
Animal Health News & Notes for December 3, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for December 3, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news 2010 Flea Study 2011 Industry Overview earnings news Del Monte other news Bioniche Dechra Del Monte Genitrix Life Technologies MiracleCorp Norbrook Labs Perdue Thorn BioScience *********************************** COMING NEXT WEEK US FLEA CONTROL AND HEARTWORM MARKETS 2010 UPDATE Brakke Consulting will soon be publishing our 2010 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products The report also includes a 2010 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm Markets is available for a purchase price of $5,500. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com to pre-order the report, or for more information visit our website at www.BrakkeConsulting.com
;
December 3, 2010
New report profiles the US flea, tick and heartworm markets
A new study from Brakke Consulting takes an in-depth look at flea, tick and heartworm products, the largest segment of the companion animal market. ”The flea control and heartworm preventatives market has been one of the most innovative areas in animal health, with a variety of new active ingredients and novel formulations,” said Lynn Fondon, senior consultant of Brakke Consulting. “Sales of flea control products have tripled in size since the introduction of Program, the first of the new-generation products, in 1995.” The study, The US Flea Control and Heartworm Markets, profiles the veterinary and OTC markets for flea and tick products and heartworm preventatives, including veterinary product sales and pricing, advertising expenditures, and new and developing products. The report also includes a survey of small animal veterinarians. “This year’s study is especially interesting because of Bayer’s move into the OTC channel in February 2010, as well as Frontline Top Spot going off-patent this year,” comments Dr. Fondon. The report – published annually by Brakke for the past 14 years – gathered information from a variety of sources, including published information, industry interviews and a survey of over 200 small animal veterinarians. The US Flea Control and Heartworm Markets report is available from Brakke Consulting for $5,500. For more information, interested companies should contact Lynn Fondon at 972.243.4033. About Brakke
;
Animal Health News & Notes for November 24, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 24, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news 2010 Flea Study 2011 Industry Overview earnings news Central Garden & Pet Webster other news Digital Angel E.I. Medical Imaging Gimborn Pet Specialties Midmark MiracleCorp Products Newmed Pfizer scil *********************************** COMING SOON! US FLEA CONTROL AND HEARTWORM MARKETS 2010 UPDATE Brakke Consulting will soon be publishing our 2010 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products The report also includes a 2010 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 24, and $5,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or
;
November 24, 2010
Animal Health News & Notes for November 19, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 19, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news 2010 Flea Study earnings news Alpharma Animal Health International Heska PetMed Express PetSmart other news Animalcare Aurora Pharmaceuticals Bayer Blazer Labs GenomIdea Helia Medical Meiji Seika Kaisha Petmate Piedmont Pharmaceuticals Quincy Animal Health Teva Vetoquinol Vical *********************************** COMING SOON! US FLEA CONTROL AND HEARTWORM MARKETS 2010 UPDATE LAST CHANCE FOR EARLY-BIRD DISCOUNT Brakke Consulting will soon be publishing our 2010 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products The report also includes a 2010 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 24, and $5,500 after
;
November 19, 2010
Animal Health News & Notes for November 12, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 12, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news 2010 Flea Study AnimalHealthJobs.com earnings news Bioniche Digital Angel ImmuCell other news Australian Veterinary Stem Cells JGB Distributing Neogen Putney Radio Systems Vet-Stem *********************************** COMING SOON! US FLEA CONTROL AND HEARTWORM MARKETS 2010 UPDATE ORDER NOW FOR EARLY-BIRD DISCOUNT Brakke Consulting will soon be publishing our 2010 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: – an overview of the veterinary and OTC flea control markets – Product descriptions, prices, and sales for the leading veterinary flea and heartworm products The report also includes a 2010 survey of over 200 veterinarians regarding topics such as product usage, brand switching, the effect of the economy on product sale; the impact of product sales outside the veterinary clinic channel; and developing resistance to new-generation products. The report on the US Flea Control & Heartworm Markets will be available for a purchase price of $4,995 if ordered by WEDNESDAY, NOVEMBER 24, and $5,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com
;
November 12, 2010
Animal Health News & Notes for November 5, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for November 5, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news market research earnings news MWI Pfizer other news Bayer (management) Bayer (Bomac) Bomac Sedona Pure Pets VetCentric Veterinary Diagnostics Institute Webster ************************************ COMPANY EARNINGS RELEASES > Pfizer Inc. reported financial results for third-quarter 2010. Animal health revenues were $860 million, an increase of 27%, reflecting the addition of the Fort Dodge legacy products in October 2009. (PRNewswire) > MWI Veterinary Supply, Inc. announced financial results for its fiscal year ended September 30, 2010. Total revenues were $1.23 billion for fiscal year 2010, 31% higher than revenues for fiscal year 2009. 14% of the increase was due to organic growth in the US and 17% was related to the acquisition of Centaur Services Ltd in February 2010. Net income was $33.4 million for fiscal year 2010, 34% higher than net income for fiscal year 2009. (company website) ************************************ COMPANY NEWS RELEASES > Bayer announced the appointment of Jean-Luc Lowinski as the new head of its animal health division, effective November 1, 2010. In his new position, he succeeds Lykele van der Broek who will be appointed COO of Bayer CropScience. Previously
;
November 5, 2010
Animal Health News & Notes for October 29, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 29, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news market research earnings news Abaxis Bayer Butler Schein Hill’s Intervet/Schering-Plough Merial Ridley other news ALLPRO Imaging Boehringer Ingelheim Vetmedica Greenies ************************************ COMPANY EARNINGS RELEASES > Merck & Co., Inc. announced financial results for the third quarter of 2010. Sales for animal health division Intervet/Schering-Plough totaled $687 million for the third quarter of 2010, a 3% increase over I/SP’s 2009 third quarter results, reflecting continued solid performance among poultry, swine and aquatic products. (company press release) > Sanofi-Aventis reported results for the third quarter of 2010. Net sales of Merial were $667 million in the third quarter, up 9% (+7% on a reported basis). (company website) > Bayer reported results for the third quarter of 2010. Animal health sales increased 13% (4% after adjusting for currency effects) to EUR 284 million ($387 million). (company website) > Colgate-Palmolive Company announced results for the third quarter of 2010. Hill’s sales declined 2% during the quarter to $521 million. (company website) > Abaxis reported results for the second quarter of fiscal 2011 ended September 30, 2010. Veterinary market sales were $27 million, up
;
October 29, 2010
Animal Health News & Notes for October 22, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 22, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news recruiting earnings news Elanco IDEXX Nestle PetMed Express VCA Antech Vétoquinol Virbac other news Dechra Veterinary Products DermaPet Digital DVM Hill’s Phillips Feed and Pet Supply Super-Dog Pet Food Teva ************************************ COMPANY EARNINGS RELEASES > Eli Lilly reported results for the third quarter of 2010. Worldwide sales of animal health division Elanco were $353 million, an increase of 12% compared with the third quarter of 2009. US sales grew 12%, due primarily to increased sales of Comfortis. (company press release) > Virbac SA reported results for the third quarter of 2010. Net sales for the quarter were EUR 154 million ($210 million). The combination of a 13% internal growth with the addition of the product ranges acquired from Pfizer in Australia early this year and the weakening of the euro resulted in a 26% growth rate in the third quarter. (company website) > Vétoquinol SA reported results for the third quarter of 2010. The company generated revenues of EUR 69 million ($94 million) in the third quarter of 2010, an increase of 11% compared with the same period in the preceding
;
October 22, 2010
Animal Health News & Notes for October 15, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 15, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news acquisitions and licensing earnings news KMG Chemicals Provimi other news 4legPharma AgFeed Industries Alpharma Avivagen Animal Health Blue Buffalo Chemaphor Digital Angel DNA My Dog Henry Schein Imugene Intervet/Schering-Plough (vaccine) Intervet/Schering-Plough (merger) Merck Merial Novartis Pfizer Provet Holdings ************************************ COMPANY EARNINGS RELEASES > KMG Chemicals, Inc. announced financial results for the fourth quarter and fiscal year ended July 31, 2010. Animal Health Products generated net sales of $3.9 million, approximating last year’s $3.8 million. (Market Wire) > Provimi Pet Food recorded sales of EUR 115 million ($140 million) for the first six months of 2010, a 6% increase on the first half of 2009. (PRNewswire) ************************************ COMPANY NEWS RELEASES > According to a Bloomberg report, Sanofi-Aventis SA and Merck & Co. plan to sell animal-health assets valued at about $1 billion after agreeing to combine their veterinary medicine businesses, Merial and Intervet/Schering-Plough, this year. Selling the assets may allow Sanofi and Merck to resolve antitrust concerns and complete the joint venture. (Veterinary Advantage) > Pfizer Inc. and King Pharmaceuticals, parent company of Alpharma Animal Health, announced that they have
;
October 15, 2010
Animal Health News & Notes for October 8, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 8, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news acquisitions and licensing other news Applica Consumer Products Biogal Galed Labs Intervet/Schering-Plough Modern Veterinary Therapeutics NASSA OurPet’s Company Provimi ************************************ COMPANY NEWS RELEASES > Intervet/Schering-Plough Animal Health announced the launch of Posatex (1% Orbifloxacin, 0.1% Mometasone Furoate Monohydrate and 0.1% Posaconazole, Otic Suspension), a new once-a-day treatment for otitis in dogs. The seven-day treatment is designed to make compliance easier and bring fast relief to dogs suffering from this painful condition. (company press release) > Modern Veterinary Therapeutics and Biogal Galed Labs announced that the USDA-Center for Veterinary Biologics has approved Canine VacciCheck diagnostic kit. Canine VacciCheck is indicated for the detection of antibodies to infectious canine hepatitis, canine parvovirus and canine distemper in dog whole blood or serum. Canine VacciCheck is based on the patented ImmunoComb technology and is offered with CombScan software which allows a reading of the results within only a few seconds. (company press release) > OurPet’s Company announced that the US Court of Appeals for the Federal Circuit issued its decision in favor of OurPet’s Company and its SmartScoop Self Scooping Litter Box. The Court’s decision reverses
;
October 8, 2010
Brakke Consulting Announces Participation in KCAHC Corridor Conversations
Ron Brakke of Brakke Consulting will be participating as a presenter in the upcoming Kansas City Animal Health Corridor’s Corridor Conversations conference in Kansas City On October 7, 2010. Brakke’s presentation is entitled “The Animal Health Industry in Transition: The Impact of Recent Manufacturer & Distributor Mergers.” “We are pleased to have this opportunity to participate in the Corridor Conversations in Kansas City,” said Ron Brakke, president of Brakke Consulting, Inc. “This presentation will give us an opportunity to share with the animal health industry our experience and insights into the dynamic nature of the industry in which we work,” he added. About Brakke Consulting, Inc.: Established in 1986, Brakke Consulting provides a full range of consulting services, including assistance with general business issues, acquisitions and divestitures, intellectual property (IP) transfer, market research, executive search, and veterinary practice management. The firm also markets a variety of syndicated market studies. More information about the firm can be found at www.brakkeconsulting.com. printer friendly version
October 7, 2010
Animal Health News & Notes for October 1, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for October 1, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news recruiting other news Aceto Canidae Pet Foods Digital Angel Huvepharma Merial Petspace PositiveID ************************************ COMPANY NEWS RELEASES > Merial announced the addition of Equioxx (firocoxib) Injection to its Equioxx brand of oral analgesics for horses. Equioxx Injection provides 24 hours of prescription osteoarthritis pain relief in just one daily dose. (company press release) > Aceto Corp announced that it has received the USDA’s approval to import and sell canine vaccines in the US, marking the first step towards its long-term plan to market a line of veterinary products. The company, which distributes pharmaceuticals and specialty chemicals, said it expects to start marketing the four-in-one vaccine to veterinary users in the first half of 2011. (Reuters) > Digital Angel Corporation announced that its Board of Directors unanimously rejected PositiveID Corporation’s unsolicited non-binding proposal for acquisition. The Board believes the proposed offer is less attractive than other informal indications of interest the Board of Directors has received. The Board is in the process of engaging a financial advisor to independently value the company and to advise it on all available strategic alternatives including maintaining
;
October 1, 2010
Animal Health News & Notes for September 24, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 24, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news recruiting History of the Animal Health Industry earnings news Neogen other news Alltech Animal Health International Dechra Intervet/Schering-Plough Martek Biosciences Modern Veterinary Therapeutics Professional Veterinary Products Pulse Veterinary Technologies Veterinary Products Laboratories ************************************ COMPANY EARNINGS RELEASES > Neogen Corporation announced that its net income for the first quarter of FY 2011, which ended Aug. 31, increased 33% to $5.8 million. First quarter revenues also increased 33% from the previous year to $43 million. About half the increase is attributable to the addition of the BioKits and GeneSeek product lines. Neogen’s Animal Safety Division led the company’s first quarter revenue increase, with sales up 39% to $21 million in FY 2011. (company press release) ************************************ COMPANY NEWS RELEASES > Intervet/Schering-Plough Animal Health announced the approval of Nobivac Lepto4, the first and only four-way canine leptospirosis vaccine to be approved for protecting dogs against mortality. Nobivac Lepto4 was also shown to prevent clinical disease. The vaccine is indicated to protect dogs from L. canicola, L. icterohaemorrhagiae, L. pomona and L. grippotyphosa, and is available as a standalone or as a combination vaccine. (Veterinary
;
September 24, 2010
Animal Health News & Notes for September 17, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 17, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news market research services other news AgFeed Industries Ainsworth Pet Nutrition Anacor Pharmaceuticals Dad’s Pet Care Dechra Digital Angel Elanco Hill’s M2P2 Macleod Pharmaceuticals MWI Nestle Purina PetCare Pfizer Positive ID PurinaCare Insurance Waggin’ Train ************************************ COMPANY NEWS RELEASES > Pfizer Animal Health announced it has gained full licensure from the USDA for its FluSure Pandemic swine vaccine. The vaccine helps pork producers protect their herds from the pandemic H1N1 (pH1N1) strain of Swine Influenza Virus (SIV). (company press release) > MWI Veterinary Supply announced a new affiliation with Hill’s Pet Nutrition, providing access of the full line of Hill’s Prescription Diets and top selling products from the Science Diet line to MWI customers utilizing the Vetstreet Home Delivery service. (company press release) > Dechra Veterinary Products announced it has received FDA approval to market Equidone Gel, which contains the active ingredient domperidone. Equidone Gel is a patent-protected new animal drug approval (NADA) and the only FDA approved product to prevent fescue toxicosis in periparturient mares. (company press release) > Macleod Pharmaceuticals, Inc., announced the launch of apple-flavored Uniprim. It is
;
September 17, 2010
Animal Health News & Notes for September 10, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 10, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news Brakke/Bayer veterinary research initiative market research services earnings news Animal Health International Bioniche Dechra other news Abbott AKC Canine Health Foundation Bayer digitalDVM Hartz HealthyPet Heartland Pet Care Hill’s IDEXX Intervet/Schering-Plough Milk Products Nestle Purina PetCare Novartis Pfizer scil animal care Seasons Pet Food ULURU Veterinary Metrics Webster ************************************ COMPANY EARNINGS RELEASES > Dechra Pharmaceuticals PLC released preliminary results for the year ended June 30, 2010. Group revenue increased 5.5% to GBP 369 million ($556 million) for the year. Total European Pharmaceuticals sales for the year were GBP 85 million ($128 million), while US Pharmaceuticals sales were GBP 11 million ($16 million). (company website) > Bioniche Life Sciences Inc. announced financial results for its 2010 fiscal year ended June 30, 2010. Total revenues were C$46 million (US$44 million), an increase of 38% compared to the prior year. Consolidated revenues related to Bioniche Animal Health product sales for the fiscal year were $C27 million (US$26 million), a 19% decline as compared to fiscal 2009. (MarketWire) > Animal Health International, Inc. reported its financial results for the company’s fiscal year ended June 30,
;
September 10, 2010
Brakke Consulting and Bayer Animal Health Announce Research Project to Help Reverse Decline in Veterinary Visits
A comprehensive research initiative was announced today by Bayer HealthCare’s Animal Health Division and Brakke Consulting. The research initiative will investigate reasons for the decline in companion animal veterinary visits during the past decade and identify ways to reverse the trend. While the population of dogs and cats in the U.S. has steadily increased year over year, one million fewer veterinary visits were recorded in 2006 versus 2001, according to data published by the American Veterinary Medical Association. A more recent study demonstrated that the decline has accelerated during the recent recession, with more than half of veterinarians seeing stagnant to declining visits. Bayer Animal Health and Brakke Consulting’s research will seek to understand the causes behind the reduction in companion animal veterinary visits, and to determine how veterinarians can increase them. “Bayer Animal Health is committed to developing solutions to increase awareness of the importance of veterinary care visits to pet health,” said Peter Ryan, vice president of Bayer Animal Health’s companion animal business unit. “Pets that are not routinely taken to the veterinarian are pets that are not receiving the medical attention they need to live healthy lives.” Bayer Animal Health and Brakke Consulting are collaborating on the study with the National Commission on Veterinary Economic Issues (NCVEI), a professional organization dedicated to improving economic conditions in veterinary medicine.
;
September 3, 2010
Animal Health News & Notes for September 3, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for September 3, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news mergers, acquisitions, technology licensing earnings news Del Monte Provimi other news Franck’s Pharmacy North American Compendiums Pfizer Synbiotics Van Beek Global ************************************ COMPANY EARNINGS RELEASES > The Provimi Group announced consolidated results for the first six months of the year. Revenue was EUR 893 million ($1.09 billion), an increase of 6% compared to the comparable period in 2009. (company press release) > Del Monte Foods reported net sales for the first quarter fiscal 2011 ended August 1, 2010. For the first quarter, Pet Products net sales were $427 million, an increase of 3.6% over sales in the prior year period. (Business Wire) ************************************ COMPANY NEWS RELEASES > The FDA announced the approval of a New Animal Drug Application for Pfizer’s PropoClear (propofol) for intravenous use in cats and dogs for the induction and maintenance of anesthesia and for induction followed by maintenance with an inhalant anesthetic. PropoClear is the first lipid-free injectable propofol and offers a 28-day broached vial shelf life. The product was launched by Fort Dodge in the EU in 2009. (FDA) > Van Beek Global announced
;
Animal Health News & Notes for August 27, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 27, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS Brakke news Executive and sales force recruiting earnings news Webster other news Bioniche Ceva Elanco HealthPro Brands J.D. Heiskell Land O’Lakes Purina Feed Midwest Veterinary Supply Pfizer Professional Veterinary Products Summit VetPharm ************************************ COMPANY EARNINGS RELEASES > Patterson Companies, Inc. reported consolidated results for the first quarter of fiscal 2011 ended July 31. Sales of the Webster Veterinary Supply unit increased 6% in the first quarter of fiscal 2011 to $180 million. (company website) ************************************ COMPANY NEWS RELEASES > Pfizer Animal Health announced the launch of InForce 3 Respiratory Vaccine, new three-way respiratory cattle vaccine. The intranasal vaccine offers disease prevention against bovine respiratory syncytial virus (BRSV), infectious bovine rhinotracheitis (IBR) and parainfluenza type 3 (PI3). (CattleNetwork) > Ceva announced it has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquire a majority share of Sumitomo’s animal health subsidiary, Summit VetPharm, LLC. Sumitomo Corporation will remain a minority shareholder in the new North American CEVA companion animal business, which will include the assets of Summit VetPharm. Financial terms were not disclosed. (company press release) > Professional
;
August 27, 2010
Animal Health News & Notes for August 20, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 20, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news Mergers, acquisitions, divestitures, technology licensing earnings news JBS S.A. PetSmart other news Embrace Pet Insurance Modern Veterinary Therapeutics Pet Supplies “Plus” Professional Veterinary Products Quincy Animal Health ************************************ LAST WEEK TO REGISTER! KC ANIMAL HEALTH CORRIDOR HOMECOMING 2010 MONDAY, AUGUST 30 5:30 – 9:00 pm The Kansas City Animal Health Corridor cordially invites the animal health industry to join them for an exclusive gathering of animal health CEOs and industry leaders from across the country at its annual Homecoming Event in Kansas City. The event will feature an appearance by Jack Hanna, Director Emeritus of the Columbus Ohio Zoo and Aquarium. In addition, the Iron Paw award will be presented to animal health industry leader Bob Wheeler, former CEO of Hill’s Pet Nutrition. To register, go to www.kcanimalhealth.com/homecoming ************************************ COMPANY EARNINGS RELEASES > PetSmart, Inc. reported net income of $48 million in the second quarter of 2010, compared to $39 million in the second quarter of 2009. Total sales for the second quarter of 2010 increased 6% to $1.4 billion. Comparable store sales grew 5% in the second quarter. (company
;
August 20, 2010
Animal Health News & Notes for August 13, 2010
printer friendly version ************************************ Brakke Consulting’s Animal Health News & Notes for August 13, 2010 Copyright © Brakke Consulting, Inc. Editor: Lynn Fondon, DVM MBA ************************************ IN THE NEWS: Brakke news Mergers, acquisitions, divestitures, technology licensing earnings news Alpharma Digital Angel ECO Animal Health Nestle Tyson Foods other news Biolex Therapeutics Boehringer Ingelheim Vetmedica Cosmic Pet Products Fort Dodge Globion India Lohmann AH Menu Foods Merial OurPet’s Company Simmons Pet Food Suguna Tridelta Development ************************************ KC ANIMAL HEALTH CORRIDOR HOMECOMING 2010 MONDAY, AUGUST 30 5:30 – 9:00 pm The Kansas City Animal Health Corridor cordially invites the animal health industry to join them for an exclusive gathering of animal health CEOs and industry leaders from across the country at its annual Homecoming Event in Kansas City. The event will feature an appearance by Jack Hanna, Director Emeritus of the Columbus Ohio Zoo and Aquarium. In addition, the Iron Paw award will be presented to animal health industry leader Bob Wheeler, former CEO of Hill’s Pet Nutrition. To register, go to www.kcanimalhealth.com/homecoming ************************************ COMPANY EARNINGS RELEASES > King Pharmaceuticals, Inc. announced results for the second quarter ended June 30, 2010. Net revenue from the Alpharma Animal Health business totaled $85 million during the second quarter of 2010, an increase of 2% compared
;
August 13, 2010
Page 45 of 72
English 
Portuguese 
Japanese 
Chinese